English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background The development of an effective malaria vaccine is recognized as one of the most promising approaches that would provide a cost-effective intervention for addition to the currently available malaria control measures. Since the fully annotated P. falciparum genome has become available in 2002, reverse vaccinology represents a new opportunity to identify novel malaria vaccine candidate antigens. Screening of predicted P.falciparum open reading frames for proteins that could elicit parasite-inhibitory antibodies has led to the identification of the Cysteine-Rich Protective Antigen (CyRPA) as promising blood-stage candidate protein for inclusion in a malaria subunit vaccine.